跳至主要内容
临床试验/CTRI/2018/03/012515
CTRI/2018/03/012515进行中(未招募)未知

Efficacy and safety of intralesional Mumps-Measles-Rubella vaccine in the treatment of viral wart(s): A Double Blind, Placebo Controlled Randomised Clinical Trial

Medical College Kolkata0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • i.Patients having clinically diagnosed wart(s).
  • ii.Patients who give their informed consent.
  • iii.Patients not having received any anti-wart treatment in the past 4 weeks
  • iv.Lack of viral diseases such as herpes and/or bacterial infections such as impetigo.

排除标准

  • i.Pregnant and lactating women.
  • ii.Any evidence of immunosuppression (eg. HIV infection, organ transplantation, long term steroid use etc.).
  • iii.Any other systemic disease (eg. liver or kidney disorder).
  • iv.Presence of mucosal wart(s).
  • v.Presence of ulcerated or inflamed wart(s).
  • vi.Presence of wart(s) in face proper.
  • vii.Patients who participated in a clinical trial in the last three months.
  • viii.Patients not giving consent

研究者

相似试验